Treatment of sleep disorders
AssigneeEvotec International GmbH
InventorsJohn Alan Kemp, Ian Michael Hunneyball, Timothy Tasker
Life of this patent
Estimating the term…
Abstract
The use of 7-chloro-3-(5-dimethylaminomethyl-[1,2,4]oxadiazol-3-yl)-5methyl-4,5-dihydro-imidazol[1,5,-a][1,4]benzodiazepine-6-one or its pharmaceutically acceptable salt for treating various types of insomnia.
Claims2
Use of a compound of formula (II) or a pharmaceutically acceptable salt thereof in the preparation of a medicament for treating maintenance insomnia and/or treating terminal insomnia in a human in need thereof
Use of a compound of formula (II) or a pharmaceutically acceptable salt thereof in the preparation of a medicament for treating insomnia in a human in need thereof
- wherein the human is at least 65 years old.
Dependencies are inferred from the claim text.